Open access
Oct 2026
Targeting TLR4 alleviates the progression of experimental autoimmune encephalomyelitis by regulating central resident cells and Th1/Th17 cell differentiation
Results demonstrate that targeting TLR4 simultaneously curtails pathogenic T-cell differentiation and local neuroinflammation, establishing TLR4 as a dual-action therapeutic target for MS.
E. Du, K. Lei, Wei Deng et al.
· Frontiers in Immunology · 0 citations